Navigation Links
Micromet Added to NASDAQ Biotechnology Index
Date:11/26/2008

linatumomab, or MT103. It is in a phase 2 clinical trial for the treatment of patients with acute lymphoblastic leukemia and a phase 1 clinical trial for the treatment of patients with non-Hodgkin's lymphoma. Micromet is developing blinatumomab in collaboration with MedImmune, LLC, a subsidiary of AstraZeneca plc. Micromet's second BiTE antibody in clinical development is MT110, which targets the epithelial cell adhesion molecule (EpCAM). The Company owns all rights to MT110, which is currently in a phase 1 clinical trial for the treatment of patients with solid tumors. The Company's third clinical stage antibody is adecatumumab, also known as MT201, a traditional human monoclonal antibody that targets EpCAM-expressing solid tumors. Micromet is developing adecatumumab in collaboration with Merck Serono in a phase 1b clinical trial evaluating adecatumumab in combination with docetaxel for the treatment of patients with metastatic breast cancer. Micromet licensed a fourth clinical stage antibody, MT 293, to TRACON Pharmaceuticals, Inc. MT293 is being developed in a phase 1 clinical trial for the treatment of patients with cancer. The Company's preclinical programs include MT203 being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, psoriasis, or multiple sclerosis. Additional BiTE antibodies, targeting CEA, CD33, Her2, EGFR and MCSP, respectively, are in different stages of preclinical development.

Forward-Looking Statements

This release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. The
'/>"/>

SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
2. Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
3. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
4. Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference
5. Micromet to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007
6. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
7. Micromet to Present at the 2007 RBC Capital Markets Healthcare Conference on December 12, 2007
8. Micromet to Present at Two Upcoming Investor Conferences
9. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
10. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
11. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... GA (PRWEB) September 15, 2014 ... http://www.hydrodynamics.com ) announced today that it will be ... Estates, CA ( http://www.proteaf.com ) for implementing its ... high value continuous processing. Continuous flow chemistry ... the chemical, pharmaceutical and petrochemical markets for decades. ...
(Date:9/14/2014)... (PRWEB) September 15, 2014 UMBC’s ... held on Tuesday, October 21, 2014, from 12:00 to ... of the program’s innovative curriculum and practice-oriented instruction, designed ... graduate degree can help advance their career in the ... RSVP online . , About UMBC’s Biotechnology Graduate ...
(Date:9/14/2014)... regulate protein functions in a wide variety of ways, ... a protein can take on another form and perform ... that fold wrongly can cause serious diseases such as ... also have a tendency to "infect" other molecules of ... fibrils or plaques. These amyloids can damage cells and ...
(Date:9/14/2014)... when it comes to survival strategies. They often create ... for example during treatment with antibiotics. A biofilm is ... slime capsule consisting of sugar chains and "curli". ... the first time created a detailed three-dimensional image of ... the bacterial cell wall, a crucial step in the ...
Breaking Biology Technology:Hydro Dynamics Partners with the Continuous Flow Chemistry Experts of Proteaf Technologies 2UMBC Biotechnology Graduate Programs’ Virtual Info Session, October 21, 2014 2Measuring modified protein structures 2Measuring modified protein structures 3New insights in survival strategies of bacteria 2
... Every surgical operation requires proper wound closure to ensure ... start-up business has received a $100,000 federal grant to ... Corp ., which develops tissue repair products and advanced ... Small Business Innovation Research grant. , ,The ...
... - With the U.S. economy showing alternating signs of ... to business organizations that might want to slow the ... a housing-induced recession. , ,The Information Technology and ... the Economic Benefits of the Information Technology Revolution, focused ...
... Evansville, Wis . - Gov. Jim Doyle may ... a 62,400-square-foot biodiesel plant that will be built here over ... made it possible. , ,The $60 million plant, to be ... fuel producer, will generate 45 million gallons of fuel per ...
Cached Biology Technology:Study affirms information technology-productivity link 2Study affirms information technology-productivity link 3Investors raise $25 million for biodiesel plant 2Investors raise $25 million for biodiesel plant 3
(Date:9/12/2014)... September 12, 2014 ... ) has announced the addition of the ... report to their offering. ,     (Logo: ... 2014 is a professional and in-depth study ... fingerprint lock industry. , ,The report provides ...
(Date:9/12/2014)... Research and Markets ( ... the  "Global Facial Recognition Market (2D Facial ... - Industry Analysis, Size, Share, Growth, Trends ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... was valued at USD 1.17 billion in ...
(Date:9/12/2014)... Sept. 12, 2014 Research and Markets ... IC Card Management System Industry Report 2014" report ... Card Management System Industry Report 2014 is a professional ... global IC card management system. The report ... classifications, applications and industry chain structure. The IC card ...
Breaking Biology News(10 mins):Global Fingerprint Lock Industry Report 2014 2Global Facial Recognition Market (2D Facial Recognition, 3D Facial Recognition, and Facial Analytics) - Trends and Forecast to 2020 2Global Facial Recognition Market (2D Facial Recognition, 3D Facial Recognition, and Facial Analytics) - Trends and Forecast to 2020 3Global IC Card Management System Industry Report 2014 2
... Obesity rates in the United States increased from 14.5% of ... 2009-2010. It,s believed that one contributing factor to expanding waistlines ... the ability to control energy intake may be affected by ... rate may impair the relationship between the sensory signals and ...
... the rapid and non-invasive characteristics and may ... Chunhua Chen and colleagues from Peking University, ... normobaric oxygen before focal cerebral ischemia, neurological ... reduced; the expression of hypoxia-inducible factor-1α, Notch-1, ...
... triangle depicting how many servings of each food group you ... MyPlate - the circle showing what a healthy meal looks ... Department of Agriculture (USDA) to help American consumers put the ... prompts us to think about what,s on our plate, illustrating ...
Cached Biology News:Slower-paced meal reduces hunger but affects calorie consumption differently 2Slower-paced meal reduces hunger but affects calorie consumption differently 3Who is using MyPlate? 2
Anti-ACTH Immunogen: Porcine ACTH conjugated to BSA. Available Date: 38566...
Synaptotagmin, phosphoSer309...
... Immunogen: ... region encompassing the human, mouse, ... Accession Number: ... Assurance: Routinely evaluated by ...
Goat polyclonal to PPP2R5D Immunogen: Peptide with sequence KRAEEFLTASQEAL, from C Terminus of the protein sequence according to NP_006236...
Biology Products: